NEUROCRINE BIOSCIENCES INC Collaboration Agreements
9 Contracts & Agreements
- Collaboration and License Agreement dated November 22, 2021 between Heptares Therapeutics Limited and the Company (Filed With SEC on February 11, 2022)
- Collaboration and License Agreement dated March 31, 2015 between Mitsubishi Tanabe Pharma Corporation and the Company (Filed With SEC on May 5, 2021)
- First Amendment to Collaboration and License Agreement Dated August 31, 2011 between the Company and Abbott International Luxembourg S.a.r.l (Filed With SEC on May 5, 2021)
- Collaboration Agreement dated June 15, 2010, by and between Abbott International Luxembourg S.a.r.l. and the Company as amended on August 31, 2011 (Filed With SEC on May 5, 2021)
- Amendment No. 1 to Collaboration and License Agreement dated June 14, 2019 between Voyager Therapeutics, Inc. and the Company (Filed With SEC on July 29, 2019)
- COLLABORATION AGREEMENT dated June 15, 2010 by and between AbbottInternational Luxembourg S.à r.l. and Neurocrine Biosciences, Inc. EXHIBIT INDEX (Filed With SEC on February 11, 2016)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on April 30, 2015)
- COLLABORATION AGREEMENT dated June 15, 2010 by and between Abbott International Luxembourg S.à r.l. and Neurocrine Biosciences, Inc. (Filed With SEC on July 29, 2010)
- Contract Number: 43031148 COLLABORATION AND LICENSE AGREEMENT Dated June 16, 2010 BY AND BETWEEN BOEHRINGER INGELHEIM INTERNATIONAL GmbH AND NEUROCRINE BIOSCIENCES, INC. TABLE OF... (Filed With SEC on July 29, 2010)
